Candriam Equities L Biotech.I-H EUR Acc/ LU1006082199 /
NAV2024-06-10 | Chg.+6.2900 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
2,092.5601EUR | +0.30% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2016 | -23.24 | -4.43 | 3.75 | 3.78 | 5.33 | -8.43 | 12.46 | -2.53 | 3.75 | -12.49 | 8.75 | -2.94 | -19.97% |
2017 | 5.35 | 6.80 | -0.20 | 1.09 | -3.22 | 9.15 | 2.42 | 6.37 | 0.68 | -6.52 | 0.12 | 1.45 | +24.87% |
2018 | 6.60 | -4.86 | -2.17 | -3.34 | 4.39 | 0.63 | 4.29 | 3.92 | -2.21 | -14.22 | 3.85 | -8.55 | -13.02% |
2019 | 12.85 | 3.33 | -0.81 | -5.08 | -4.94 | 9.21 | -2.52 | -2.51 | -4.38 | 10.29 | 11.72 | 2.21 | +30.43% |
2020 | -5.35 | -1.19 | -5.42 | 12.40 | 9.51 | 1.27 | -2.96 | 0.83 | 0.64 | -2.75 | 9.44 | 2.92 | +18.93% |
2021 | 1.81 | -2.57 | -4.35 | 2.71 | -2.27 | 6.35 | -1.45 | 3.89 | -4.27 | 0.17 | -4.38 | 2.32 | -2.71% |
2022 | -10.88 | -1.96 | 5.39 | -7.76 | -3.50 | 2.63 | 4.48 | 0.83 | -2.35 | 6.56 | 5.77 | -3.11 | -5.50% |
2023 | 2.75 | -5.94 | 0.32 | 2.02 | -1.38 | 1.02 | -0.32 | -0.34 | -4.46 | -6.26 | 5.71 | 13.23 | +4.95% |
2024 | 1.22 | 1.20 | -0.07 | -6.27 | 4.01 | 3.08 | - | - | - | - | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 15.90% | 17.36% | 16.32% | 19.99% | 22.63% |
Sharpe ratio | 0.18 | 1.31 | 0.17 | -0.24 | 0.17 |
Best month | +13.23% | +13.23% | +13.23% | +13.23% | +13.23% |
Worst month | -6.27% | -6.27% | -6.27% | -10.88% | -10.88% |
Maximum loss | -11.21% | -11.21% | -15.74% | -30.29% | -32.04% |
Outperformance | +1.76% | - | +1.73% | -5.87% | +3.46% |
All quotes in EUR
Share classes
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
Candriam Equities L Biotechnolog... | reinvestment | 2,091.6299 | +8.93% | +4.39% | |
Candriam Equities L Biotech.C EU... | reinvestment | 225.1200 | +7.71% | +16.14% | |
Candriam Equities L Biotech.I-H ... | reinvestment | 2,092.5601 | +6.57% | -2.97% | |
Candriam Equities L Biotech.I EU... | reinvestment | 2,272.7400 | +8.98% | +18.02% | |
Candriam Equities L Biotech.I GB... | reinvestment | 3,451.6799 | +7.07% | +14.54% | |
Candriam Equities L Biotech.R GB... | reinvestment | 361.9500 | +6.80% | +18.12% | |
Candriam Equities L Biotech.R EU... | reinvestment | 332.3200 | +8.71% | +20.43% | |
Candriam Equities L Biotech.R-H ... | reinvestment | 203.4700 | +3.78% | -4.65% | |
Candriam Equities L Biotech.V2 U... | reinvestment | 1,871.0000 | +8.85% | +7.00% | |
Candriam Equities L Biotechnolog... | reinvestment | 151.3200 | - | - | |
Candriam Equities L Biotech.N US... | reinvestment | 607.8400 | +7.24% | +2.32% | |
Candriam Equities L Biotech.I US... | reinvestment | 5,722.7700 | +8.82% | +4.02% | |
Candriam Equities L Biotech.C-H ... | reinvestment | 199.9400 | +5.44% | -3.40% | |
Candriam Equities L Biotech.R-H ... | reinvestment | 208.5800 | +6.34% | -1.02% | |
Candriam Equities L Biotech.R US... | reinvestment | 271.1500 | +8.58% | +6.20% | |
Candriam Equities L Biotechnolo... | reinvestment | 853.4000 | +7.64% | +3.61% | |
Candriam Equities L Biotechnolog... | paying dividend | 779.3800 | +7.60% | +3.51% |
Performance
YTD | +2.87% | ||
---|---|---|---|
6 Months | +12.34% | ||
1 Year | +6.57% | ||
3 Years | -2.97% | ||
5 Years | +43.79% | ||
10 Years | - | ||
Since start | +39.50% | ||
Year | |||
2023 | +4.95% | ||
2022 | -5.50% | ||
2021 | -2.71% | ||
2020 | +18.93% | ||
2019 | +30.43% | ||
2018 | -13.02% | ||
2017 | +24.87% | ||
2016 | -19.97% |